Two Mayo Clinic studies published in the January 3 issue of Mayo Clinic Proceedings offer a clearer picture of the rise of hepatocellular carcinoma (HCC), or liver cancer, which has tripled in the U.S. in the last three decades and has a 10 to 12 percent five-year survival rate when detected in later stages.
The studies were funded by the National Institute of Health and the Mayo Clinic Center for Translational Science Activities.
Great work, Mayo Clinic!